|
|
|
Insider
Information: |
Steiner Mitchell Shuster |
Relationship: |
President and CEO, Dir... |
City: |
Memphis |
State: |
TN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
9,072,631 |
|
Indirect Shares
|
2,687,445 |
|
|
Direct
Value |
$6,989,952 |
|
|
Indirect Value
|
$1,001,229 |
|
|
Total
Shares |
11,760,076 |
|
|
Total
Value |
$7,991,181 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
8
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
8
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
Percentage
Gain/Loss : |
0.0%
|
-250.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCT |
Oncternal Therapeutics In... |
officerTitle |
|
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
D/D |
(50,000) |
26,500 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
officerTitle |
|
2005-12-06 |
4 |
S |
$7.44 |
$372,000 |
I/I |
(50,000) |
26,500 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2006-12-21 |
4 |
S |
$18.20 |
$3,516,240 |
I/I |
(193,200) |
0 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2007-03-14 |
4 |
S |
$22.10 |
$4,420,000 |
I/I |
(200,000) |
200,000 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-04-09 |
4 |
S |
$3.66 |
$142,264 |
I/I |
(38,923) |
2,025,208 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-04-10 |
4 |
S |
$3.59 |
$16,160 |
I/I |
(4,500) |
2,020,708 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-04-11 |
4 |
S |
$3.51 |
$93,313 |
I/I |
(26,585) |
1,994,123 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-04-12 |
4 |
S |
$3.50 |
$3,980 |
I/I |
(1,137) |
1,992,986 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-07-12 |
4 |
S |
$3.70 |
$142,683 |
I/I |
(38,563) |
1,954,423 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-07-13 |
4 |
S |
$3.76 |
$230,942 |
I/I |
(61,437) |
1,892,986 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2012-07-16 |
4 |
S |
$3.67 |
$91,778 |
I/I |
(25,035) |
1,867,951 |
0 |
- |
|
VERU |
Veru Inc |
President and CEO |
|
2020-12-16 |
4 |
S |
$9.69 |
$2,421,625 |
D/D |
(250,000) |
7,184,767 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2021-02-12 |
4 |
S |
$20.88 |
$417,688 |
I/I |
(20,000) |
190,000 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-15 |
4 |
S |
$1.50 |
$125,813 |
D/D |
(84,021) |
7,100,746 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-16 |
4 |
S |
$1.41 |
$84,128 |
D/D |
(59,788) |
7,040,958 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-17 |
4 |
S |
$1.32 |
$36,988 |
D/D |
(28,066) |
7,012,892 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-22 |
4 |
S |
$1.39 |
$9,018 |
D/D |
(6,504) |
7,006,388 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-23 |
4 |
S |
$1.35 |
$405 |
D/D |
(300) |
7,006,088 |
0 |
% |
|
VERU |
Veru Inc |
President and CEO |
|
2024-05-24 |
4 |
S |
$1.23 |
$78,102 |
D/D |
(63,379) |
6,942,709 |
0 |
% |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive OfficerOfficer |
|
2004-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,662,147 |
|
- |
|
VERU |
Veru Inc |
President and CEOOfficer |
|
2016-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
633,589 |
|
- |
|
VERU |
Veru Inc |
President and CEOOfficer |
|
2016-10-31 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
645,502 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2006-11-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
133,024 |
0 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2007-06-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
|
2010-01-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
171,990 |
28,010 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|